EGFR and colorectal cancer: The dataset was obtained by imaging cells (n = 163) stained for EREG in tissue microarrays (TMAs) from colorectal cancer patients (n = 23) (Figure 4, Figure S5 and Table S9, Supporting Information).[23, 24] The TMAs were obtained from patients classified by their response (no‐response vs. any‐response) to anti‐epidermal growth factor receptor (EGFR) treatment.